{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:27:42Z","timestamp":1751300862343,"version":"3.41.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 53-year-old woman presented with signs of Cushing syndrome with challenges in diagnosis and localization. A novel somatostatin receptor (SSTR)\u2013targeted PET\/CT with <jats:sup>68<\/jats:sup>Ga-DOTA-LM3, an SSTR antagonist, revealed a suspicious focal finding in the pancreatic head, proven to be ectopic Cushing syndrome after surgical resection. This interesting image clearly shows the potential of PET imaging with SSTR antagonists as <jats:sup>68<\/jats:sup>Ga-DOTA-LM3 in the diagnosis of ectopic Cushing syndrome.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005408","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T21:23:28Z","timestamp":1724966608000},"page":"1031-1032","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Ectopic Cushing Syndrome Localized by 68Ga-DOTA-LM3 PET\/CT"],"prefix":"10.1097","volume":"49","author":[{"given":"Moritz B.","family":"Bastian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Rosar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Burgard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Blickle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Ezziddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1002\/cncr.26029","article-title":"Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center experience","volume":"117","year":"2011","journal-title":"Cancer"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the national institutes of health","volume":"90","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"bib3-20250621","first-page":"22","article-title":"Ectopic Cushing\u2019s syndrome: clinical, diagnostic, treatment and follow-up outcomes of 12 cases of lung ectopic ACTH","volume":"2023","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijscr.2017.11.034","article-title":"Case report: ectopic Cushing\u2019s syndrome in a young male with hidden lung carcinoid tumor","volume":"42","year":"2018","journal-title":"Int J Surg Case Rep"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12328-021-01563-8","article-title":"A rare case of pancreatic neuroendocrine neoplasm causing Cushing\u2019s syndrome","volume":"15","year":"2022","journal-title":"Clin J Gastroenterol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2967\/jnumed.111.088328","article-title":"Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET\/CT","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2967\/jnumed.112.111724","article-title":"Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET\/CT within patients with gastroenteropancreatic neuroendocrine tumors","volume":"54","year":"2013","journal-title":"J Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","article-title":"Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours","volume":"34","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11102-019-00972-w","article-title":"Diagnostic utility of gallium-68-somatostatin receptor PET\/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience","volume":"22","year":"2019","journal-title":"Pituitary"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e0195802","DOI":"10.1371\/journal.pone.0195802","article-title":"The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model","volume":"13","year":"2018","journal-title":"PloS One"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00259-018-4193-y","article-title":"Biodistribution and radiation dose estimates for (68)Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2967\/jnumed.117.199760","article-title":"Sensitivity comparison of (68)Ga-OPS202 and (68)Ga-DOTATOC PET\/CT in patients with gastroenteropancreatic neuroendocrine tumors: a prospective phase II imaging study","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2967\/jnumed.122.264890","article-title":"Head-to-head comparison of (68)Ga-NODAGA-JR11 and (68)Ga-DOTATATE PET\/CT in patients with metastatic, well-differentiated neuroendocrine tumors: interim analysis of a prospective bicenter study","volume":"64","year":"2023","journal-title":"J Nucl Med"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1007\/s00259-024-06639-4","article-title":"Gallium-68 labeled somatostatin receptor antagonist PET\/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China","volume":"51","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging [Internet]"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:08:06Z","timestamp":1750532886000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005408","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2024,8,27]]}}}